Please assess the completion status of the following clinical trial:

Trial Title: TB Immunotherapy Trial With Heat-killed M. Vaccae

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed diagnosis of TB~* sputum smear positive~Exclusion Criteria:~* pregnant~* likely to be non-compliant due to drug and/or alcohol abuse~* mentally unfit to comply with treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- V7: Heat-inactivated M. vaccae pill (Type: EXPERIMENTAL): Daily pill of V7 together with standard tuberculosis therapy
- Placebo pill (Type: PLACEBO_COMPARATOR): one pill of placebo pill once per day together with standard of care TB drugs

Based on this trial design, predict the completion outcome and termination type (if applicable).